SEARCH:   Advanced

Blood, Vol. 113, Issue 13, 2888-2894, March 26, 2009 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes Blood Mielcarek et al. 113: 2888 Supplemental materials for: Mielcarek et al The following represents the reanalysis of the data-set after excluding patients with grades III/IV and I acute GVHD (81% of patients remained in the revised analysis). Files in this Data Supplement: Table S1. Characteristics of patients with grade II acute GVHD according to the initial prednisone-equivalent dose of glucocorticoids (PDF, 24 KB) Table S2. Multivariate analysis of transplant outcomes according to prednisone-equivalent dose of glucocorticoids for initial treatment of grade II acute GVHD (PDF, 16.5 KB) Figure S1. Cumulative use of glucocorticoids among patients given either “low-dose” glucocorticoids (prednisone-equivalent dose of 1 mg/kg/day; dashed line) or “standard-dose” glucocorticoids (prednisone-equivalent dose 2 mg/kg/day; solid line) for initial treatment of grade II acute GVHD (JPG, 25 KB) - In this analysis, follow-up was censored when patients returned to the care of the referring physicians. Figure S2. Cumulative incidence of secondary therapy among patients with grade II acute GVHD initially given either “low-dose” glucocorticoids (prednisone-equivalent dose of 1 mg/kg/day) or “standard-dose” glucocorticoids (prednisone-equivalent dose of 2 mg/kg/day) for treatment of acute GVHD (JPG, 52.9 KB) - Left panel, non-glucocorticoid secondary therapy; right panel, increased glucocorticoid dose or non-glucocorticoid secondary therapy. Figure S3. Cumulative incidence of invasive fungal infections among patients given either “low-dose” glucocorticoids (prednisone-equivalent dose of 1 mg/kg/day; dashed line) or “standard-dose” glucocorticoids (prednisone-equivalent dose of 2 mg/kg/day; solid line) for initial treatment of grade II acute GVHD (JPG, 21.7 KB) - This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020